A citation-based method for searching scientific literature

Massimo Santoro, Francesca Carlomagno. Cold Spring Harb Perspect Biol 2013
Times Cited: 67



Alexander Drilon, Natasha Rekhtman, Maria Arcila, Lu Wang, Andy Ni, Melanie Albano, Martine Van Voorthuysen, Romel Somwar, Roger S Smith, Joseph Montecalvo, Andrew Plodkowski, Michelle S Ginsberg, Gregory J Riely, Charles M Rudin, Marc Ladanyi, Mark G Kris. Lancet Oncol 2016
Times Cited: 278




List of shared articles



Times cited

Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development.
Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett. J Med Chem 2021
1

Progresses Toward Precision Medicine in RET-altered Solid Tumors.
Carmen Belli, Santosh Anand, Justin F Gainor, Frederique Penault-Llorca, Vivek Subbiah, Alexander Drilon, Fabrice Andrè, Giuseppe Curigliano. Clin Cancer Res 2020
14

Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?
Zhichao Tian, Xiaohui Niu, Weitao Yao. Front Oncol 2020
26

Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases.
Marialuisa Moccia, Donglin Yang, Naga Rajiv Lakkaniga, Brendan Frett, Nicholas McConnell, Lingtian Zhang, Annalisa Brescia, Giorgia Federico, Lingzhi Zhang, Paolo Salerno,[...]. Sci Rep 2021
0

ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research.
C Belli, F Penault-Llorca, M Ladanyi, N Normanno, J-Y Scoazec, L Lacroix, J S Reis-Filho, V Subbiah, J F Gainor, V Endris,[...]. Ann Oncol 2021
29

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.
Alexander Drilon, Zishuo I Hu, Gillianne G Y Lai, Daniel S W Tan. Nat Rev Clin Oncol 2018
137

State-of-the-Art Strategies for Targeting RET-Dependent Cancers.
Vivek Subbiah, Dong Yang, Vamsidhar Velcheti, Alexander Drilon, Funda Meric-Bernstam. J Clin Oncol 2020
80

A Case of CCDC6-RET Fusion Mutation in Adult Acute Lymphoblastic Leukemia (ALL), a Known Activating Mutation Reported in ALL.
Mateo Mejia Saldarriaga, Amir Steinberg, Eric A Severson, Adam Binder. Front Oncol 2019
0

Case report: identification of ERC1-RET fusion in a patient with pancreatic ductal adenocarcinoma.
Jia Ma, Baosheng Wang, Erhong Meng, Xiangpeng Meng. Gland Surg 2021
2